Abstract
5-HT receptors, 83
5-HT1B/1D receptors, 37, 384
5-HT1D agonist, 799
5-HT1D receptors, 424
5-HT1F receptors, 384
24-hour ambulatory blood pressure monitoring, 190
abdominal migraine, 552
acetaminophen, 740
acute, 354
acute treatment, 309
adenosine A1 receptor agonist, 260
age at onset, 94
age factors, 132
alien hand, 692
almotriptan, 453
analgesic, 740
analgesic overuse, 327
arteriovenous anastomoses, 37
atlanto-axial joint, 15
aura, 246, 345
autonomic phenomena, 12
autonomic symptoms, 256
basal ganglia, 2
benign cough headache, 772
Bereitschaftspotential in children, 125
blink reflex, 474
blood pressure, 190
body schema disorder, 62
bony osteophyte, 439
botulinum toxin A, 699
brain perfusion, 291
brainstem, 107
breath holding index, 288
bridging analysis, 376
BRL15572, 83
butorphanol, 282
CACNA1A, 552
calcitonin gene-related peptide, 233, 424
calcium channel, 812
capture-recapture, 361
cardiac cephalgia, 765
cardiac output, 37
carotid dissection, 557, 725
catecholamines, 226
celecoxib, 197
central neurogenic, 107
cerebral arteries, 54
cerebral autoregulation, 313
cerebral blood flow, 468
cerebral blood flow velocity, 288
cerebrovascular reactivity, 288
cervical spinal cord, 112
cervical, 15
cervicogenic headache, 165, 462, 533, 667, 829
c-fos, 384
change, 179
Chiari malformation, 780
Chiari I malformation, 772
child, 179
childhood headache, 791
childhood, 132
children, 401
chiropractic, 617
chronic, 730
chronic cluster headache, 94
chronic daily headache, 66, 190, 327, 432, 720
chronic fatigue syndrome, 720
chronic headache, 672
chronic migraine, 659
chronic tension headache, 444
chronic whiplash syndrome, 560
classification, 242
classification systems, 432
clinical trials, 633
cluster headache, 12, 33, 160, 186, 205, 317, 520, 725, 730, 758, 815, 818
cluster headache sine headache, 1, 12
cluster-like headache, 557
coenzyme Q10, 137
cognitive function, 271
complementary and alternative medicine, 331, 395
contingent negative variation, 132
contrast sensitivity, 142
coronary artery, 83
cost, 807
cough headache, 784
cranial arteries, 83
CSF leak, 780
cyclic vomiting syndrome, 552
cytokines, 303
depression, 172
disability, 172
distortion, 165
donitriptan, 37
dopamine, 2
dose-response study, 523
drug interaction, 282
EEG, 271
efficacy, 23, 416, 453
eletriptan, 23, 416
emission computed, 749
epidemiology, 361
epilepsy, 482
episodic, 730
episodic cluster headache, 94
ergotamine, 686, 807
Eulenburg, 686
evidence-based-medicine, 699
evoked potentials, 48
evolution, 624
exertional headache, 765, 780, 784
exteroceptive suppression, 444
extrapyramidal system, 2
eye movements, 271
eye pain, 195
fatigue, 720
feverfew, 523
flunarizine, 209
functional ability, 680
Gabapentin (neuronetin), 249, 409
gastric reflux, 555
genetics, 624, 758
glare, 711
glutamate, 303
hαCGRP, 54
habituation, 48
handedness, 146
head and face, 251
head pain, 395
headache, 12, 15, 23, 54, 66, 142, 165, 172, 179, 190, 201, 233, 303, 313, 320, 333, 354, 395, 617, 711, 780, 784, 807
headache associated with sexual activity, 784
headache diagnosis, 791
headache epidemiology, 462, 784
headache phase, 411
headache prevalence, 401
health-related quality of life, 818
helicobacter pylori, 222
hemicrania continua, 242, 246, 409, 563
hemiplegic migraine, 361
hereditary haemochromatosis, 317
HIS, 432
history of medicine, 686
human, 83, 112
human brainstem, 424
hydroxocobalamin, 513
hyperbaric, 730
hypercapnia, 468
hypertension, 190, 313
hypertensive encephalopathy, 313
hypnic headache, 157, 824
idiopathic headache, 699
idiopathic stabbing headache, 197
incidence, 354
indomethacin, 246, 409, 725
influence of work on headache, 462
intensity dependence, 48
International Headache Society criteria, 725
intranasal, 513
intravital microscopy, 260
intuitive colorimeter, 711
ischaemic stroke, 303
Japanese patients, 376
Japanese, 416
keratectomy, 195
kinematic analysis, 533
L-arginine-NO pathway, 33
lipid peroxidation, 222
MA subtypes, 411
magnesium sulphate, 345
major depression, 543
malignant hypertension, 313
medication overuse, 807
memory disturbances, 291
meningeal blood flow, 233
meningeal enhancement, 780
meta-analysis, 265, 634
methodological issues, 205
microvascular decompression, 201
midbrain, 107
MIG-99, 523
migraine attack, 468
migraine genes, 552
migraine headache, 555
migraine prophylaxis, 209, 523
migraine with aura, 146, 345, 411, 485, 692, 697
migraine without aura, 288, 345
migraine, 2, 23, 33, 37, 48, 54, 62, 83, 101, 107, 117, 125, 132, 137, 142, 146, 154,172, 209, 222, 256, 260, 265, 291, 309, 340, 376, 384, 411, 416, 424, 432, 444, 453, 491, 513, 543, 617, 624, 633, 659, 667, 672, 680, 686, 699, 711, 720, 791, 799, 807
mitochondria, 137
motion sickness, 117
movement-related potential, 125
muscle tenderness, 340
naproxen, 740
naratriptan, 815
nasal spray, 282
natural selection, 624
nausea, 117, 345
neck movement, 533
neck sprain, 165
neck-ache, 462
neck-shoulder pain, 340
nerve block, 520
neural network model, 48
neuralgia, 251
neurogenic vasodilation, 260
neuropeptides, 112, 730
neuropsychological assessment, 291
neuroticism, 543
new daily persistent headache, 66
nitric oxide, 33, 112, 222, 226, 233, 513, 758
nitrite, 33
nitroglycerin, 226
nitroglycerin, 749
NMR, 557
nociception, 226
occipital, 15
occipital nerve, 520
ophthalmic treatment, 711
orally disintegrating tablet formulation, 101
orgasm, 485
orthostatic headache, 439
outcomes, 659
oxygen, 730
pain, 320, 345, 411
pain characteristics, 401
pain intensity, 543
panic disorder, 543
paroxysmal headaches, 474
pathogenesis, 12
pharmacokinetics, 282
phonophobia, 345
photophobia, 117, 345, 711
photorefractive keratectomy, 195
photosensitivity, 711
pituitary microadenoma, 149
placebo control, 523
placebo effect, 205
placebo-response, 265
PNU-142633, 799
positive predictive value, 791
precision ophthalmic tints, 711
predisposing factors, 401
prednisone, 157
pregnancy, 667
prevalence, 179, 361
prevention, 491
preventive treatment, 815
prophylactic treatment, 205
prophylaxis, 265, 491, 513
propranolol, 209
prostaglandins, 233
pulsatile ocular amplitudes, 667
quality of life, 680
Raeder's syndrome, 151
recurrence, 23
recurrence, 680
reproducibility, 474
rizatriptan, 271, 309, 664, 680
rofecoxib, 309
safety, 416
sample size calculations, 474
saphenous vein, 83
SB224289, 83
scalp tenderness, 117
schoolchildren, 340
semilunar shape signal, 557
sensitivity, 791
serotonin, 226
serotonin agonists, 633
serotonin receptor, 468
sex ratio, 94, 361
Short Form 36 (SF-36), 818
side-effects, 186
sleep apnoea syndrome, 333
sleep respiratory disorders, 333
snoring, 333
socio-economic status, 672
sodium valproate, 205
somesthetic aura, 62
specificity, 791
spinal manipulation, 617
spontaneous intracranial hypotension, 439, 822
stroke, 154, 197
subarachnoid haemorrhage, 354
substance P, 424
sum of pain intensity differences, 664
sumatriptan, 83, 195, 271, 282, 453, 468, 749
SUNCT, 201, 249, 251, 812
survey, 395
Tanacetum parthenium, 523
tension-type headache, 340, 401, 699, 740
tension-type headache, 791
therapy, 186
TMJ dysfunction, 444
tolerability, 453
tomography, 749
topiramate, 186, 659
tractor work, 462
transcranial Doppler ultrasound, 288
transformed migraine, 172
treatment, 197, 491, 633, 686
trigeminal, 260
trigeminal Aδ fibres, 151
trigeminal neuralgia, 251
trigeminal neuralgia, 812
trigeminal nucleus caudalis, 112
trigeminal pain, 384
trigeminal somatosensory evoked potentials, 474
trigeminal-autonomic reflex, 256
trigger factor, 555
triptans, 633, 807
unilateral headaches, 146, 251, 409
vagal nerve stimulation, 482
verapamil, 812
vision, 142
visual pathways, 142
vitamins, 489
whiplash, 165, 533
Woakes, Edward, 686
zolmitriptan, 101, 376